Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1991; Volume 39,Issue 2
  • You have access
    Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain.
    L G Miller, W R Galpern, K Dunlap, C A Dinarello and T J Turner
    Molecular Pharmacology February 1991, 39 (2) 105-108;
  • You have access
    Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
    M M McHale, L B Cieslinski, W K Eng, R K Johnson, T J Torphy and G P Livi
    Molecular Pharmacology February 1991, 39 (2) 109-113;
  • You have access
    14, 15-cis-episulfide-eicosatrienoic acid, an 'epoxygenase' eicosanoid analog, inhibits ionophore- but not thrombin-induced platelet aggregation.
    K Bernstrom, K Malcolm, J McGee, J Maclouf, S Levy-Toledano, J R Falck and F A Fitzpatrick
    Molecular Pharmacology February 1991, 39 (2) 114-119;
  • You have access
    Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes.
    H Ji, K Sandberg and K J Catt
    Molecular Pharmacology February 1991, 39 (2) 120-123;
  • You have access
    Selective effects of activation of protein kinase C isozymes on cyclic AMP accumulation.
    F Gusovsky and J S Gutkind
    Molecular Pharmacology February 1991, 39 (2) 124-129;
  • You have access
    The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.
    C Nanoff, K A Jacobson and G L Stiles
    Molecular Pharmacology February 1991, 39 (2) 130-135;
  • You have access
    Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    E Chu, J C Drake, D M Koeller, S Zinn, C A Jamis-Dow, G C Yeh and C J Allegra
    Molecular Pharmacology February 1991, 39 (2) 136-143;
  • You have access
    Stimulation of nerve growth factor biosynthesis in developing rat brain by reserpine: steroids as potential mediators.
    M Fabrazzo, E Costa and I Mocchetti
    Molecular Pharmacology February 1991, 39 (2) 144-149;
  • You have access
    The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states.
    X Molero and L J Miller
    Molecular Pharmacology February 1991, 39 (2) 150-156;
  • You have access
    Prolonged ethanol inhalation decreases gamma-aminobutyric acidA receptor alpha subunit mRNAs in the rat cerebral cortex.
    P Montpied, A L Morrow, J W Karanian, E I Ginns, B M Martin and S M Paul
    Molecular Pharmacology February 1991, 39 (2) 157-163;
  • You have access
    Stimulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by phorbol ester: mediation by protein kinase C.
    Z M Duniec, P Nettesheim and T E Eling
    Molecular Pharmacology February 1991, 39 (2) 164-170;
  • You have access
    Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
    R Henschler, U Brennscheidt, R Mertelsmann and F Herrmann
    Molecular Pharmacology February 1991, 39 (2) 171-176;
  • You have access
    Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures.
    S Fournel-Gigleux, L Sutherland, N Sabolovic, B Burchell and G Siest
    Molecular Pharmacology February 1991, 39 (2) 177-183;
  • You have access
    Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    D M Grant, M Blum, M Beer and U A Meyer
    Molecular Pharmacology February 1991, 39 (2) 184-191;
  • You have access
    Mutations of the human beta 2-adrenergic receptor that impair coupling to Gs interfere with receptor down-regulation but not sequestration.
    P T Campbell, M Hnatowich, B F O'Dowd, M G Caron, R J Lefkowitz and W P Hausdorff
    Molecular Pharmacology February 1991, 39 (2) 192-198;
  • You have access
    [3H]opipramol labels a novel binding site and sigma receptors in rat brain membranes.
    C D Ferris, D J Hirsch, B P Brooks, A M Snowman and S H Snyder
    Molecular Pharmacology February 1991, 39 (2) 199-204;
  • You have access
    Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
    H Mount, R Quirion, I Chaudieu and P Boksa
    Molecular Pharmacology February 1991, 39 (2) 205-210;
  • You have access
    Evidence of paired M2 muscarinic receptors.
    L T Potter, L A Ballesteros, L H Bichajian, C A Ferrendelli, A Fisher, H E Hanchett and R Zhang
    Molecular Pharmacology February 1991, 39 (2) 211-221;
  • You have access
    Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands.
    R B Rothman, A Reid, A Mahboubi, C H Kim, B R De Costa, A E Jacobson and K C Rice
    Molecular Pharmacology February 1991, 39 (2) 222-232;
  • You have access
    Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs.
    Y J Hei, K L MacDonell, J H McNeill and J Diamond
    Molecular Pharmacology February 1991, 39 (2) 233-238;
  • You have access
    Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms.
    S B Jones, S P Halenda and D B Bylund
    Molecular Pharmacology February 1991, 39 (2) 239-245;
  • You have access
    3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.
    E M August, E M Birks and W H Prusoff
    Molecular Pharmacology February 1991, 39 (2) 246-249;
  • You have access
    Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    X B Kong, W P Tong and T C Chou
    Molecular Pharmacology February 1991, 39 (2) 250-257;
  • You have access
    Catabolism of 3'-azido-3'-deoxythymidine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythymidine, a highly toxic catabolite for human bone marrow cells.
    E M Cretton, M Y Xie, R J Bevan, N M Goudgaon, R F Schinazi and J P Sommadossi
    Molecular Pharmacology February 1991, 39 (2) 258-266;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 39, Issue 2
1 Feb 1991
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics